Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: Lancet Diabetes Endocrinol. 2020 Dec 18;9(2):94–105. doi: 10.1016/S2213-8587(20)30399-5

Table 5.

Odds ratios (ORs)a for thyroid cancer risk in offspring (papillary, n=1,968 and follicular, n=280) in relation to maternal and neonatal characteristics, stratified on age at diagnosis.

Papillary Follicular
<30 years 30+ years <30 years 30+ years
OR1 95% OR1 95% OR1 95% OR1 95%
Maternal characteristics
Age at birth (per birth) 0.99 0.98-1·00 1·00 0.99-1·01 0.97 0.94-1·01 0.98 0.95-1·02
Smoking during pregnancy (yes vs. no) 1·14 0.89-1·47 0.29 0.03-2·66 0.98 0.52-1·86 7·94 0.49-128
Marital status
  Married/ cohabitant 1·00 Reference 1·00 Reference 1·00 Reference 1·00 Reference
  Single/widow/divorced/other 1·08 0.91-1·28 1·00 0.82-1·21 0.83 0.52-1·33 0.98 0.59-1·63
Paternal characteristics
Age at birth (per year) 1·00 0.98-1·02 1·00 0.98-1·01 0.99 0.94-1·04 0.97 0.93-1·01
Birth characteristics
Preterm birth (yes vs. no) 1·04 0.78-1·37 0.69 0.46-1·04 1·06 0.50-2·22 1·36 0.63-2·93
Multiple birth (yes vs. no) 1·18 0.77-1·81 1·32 0.83-2·12 0.33 0.04-2·43 1·00 0.23-4·31
Cesarean delivery (yes vs. no) 0.90 0.72-1·13 0.94 0.69-1·27 1·09 0.63-1·88 1·63 0.78-3·38
Small-for-gestational age (yes vs. no) 1·22 0.86-1·75 0.94 0.62-1·43 0.28 0.04-2·06 0.80 0.24-2·64
Large-for-gestational age (yes vs. no) 1·26 0.84-1·88 1·23 0.78-1·92 0.59 0.18-1·95 0.48 0.06-3·59
Birth weight (g)
  <1,500 1·15 0.46-2·91 NE NE NE NE NE NE
  1,500-2,499 1·09 0.78-1·51 0.90 0.61-1·33 1·22 0.47-3·15 0.59 0.18-1·96
  2,500-3,499 1·00 Reference 1·00 Reference 1·00 Reference 1·00 Reference
  3,500-4,499 1·15 1·01-1·31 1·01 0.87-1·16 1·61 1·13-2·28 1·41 0.97-2·06
  4,500+ 1·30 0.87-1·93 1·31 0.87-1·97 1·00 0.35-2·90 NE NE
Birth weight (per kg) 1·11 0.99-1·25 1·11 0.97-1·26 1·44 1·06-1·97 1·31 0.92-1·88
Birth order
  1 1·00 Reference 1·00 Reference 1·00 Reference 1·00 Reference
  2 0.99 0.86-1·14 1·03 0.88-1·20 1·21 0.83-1·75 0.84 0.55-1·27
  3 0.78 0.65-0.95 0.89 0.72-1·09 0.89 0.53-1·49 0.78 0.46-1·33
  4 0.78 0.57-1·07 0.70 0.49-1·00 0.68 0.29-1·64 0.72 0.30-1·75
  5+ 1·33 0.93-1·91 0.71 0.46-1·11 0.46 0.11-1·95 0.57 0.17-1·92
Maternal conditions diagnosed before pregnancy
Diabetes (yes vs. no) 2·25 1·09-4·63 0.91 0.27-2·99 1·11 0.14-8·77 20.0 1·81-221
Hypertension (yes vs. no) 0.58 0.08-4·39 5·00 0.45-55·1 NE NE NE NE
Maternal conditions diagnosed before/during pregnancy (Denmark only)
Hypothyroidism (yes vs. no) 42·5 17·5-103 12·2 4·88-30.7 5·00 0.45-55·1 NE NE
Hyperthyroidism (yes vs. no) 9·63 3·99-23·2 14·4 6·17-33·8 NE NE 8·22 1·13-60.1
Goiter (yes vs. no) 48·7 22·8-104 77·8 30.7-197 28·4 7·66-105 NEb NEb
Thyroiditis (yes vs. no) 2·50 0.28-22·5 5·00 0.92-27·3 NE NE NE NE
Benign neoplasms (yes vs. no) 20.0 3·66-109 20.0 1·81-221 NE NE 10.0 0.63-160
Maternal conditions diagnosed during pregnancy
Gestational hypertension (yes vs. no) 0.74 0.43-1·28 0.62 0.30-1·26 NE NE 2·53 0.84-7·67
Hyperemesis (yes vs. no) 1·02 0.51-2·03 1·02 0.44-2·36 2·20 0.61-7·87 1·00 0.13-7·81
Pregnancy anemia (yes vs. no) 1·39 0.77-2·51 0.58 0.23-1·43 0.83 0.10-6·55 1·43 0.18-11·6
Gestational diabetes (yes vs. no) 1·19 0.47-3·05 1·25 0.16-9·99 2·27 0.48-10.8 NE NE
Placental abruption (yes vs. no) 0.69 0.21-2·25 0.65 0.15-2·70 1·46 0.17-12·8 NE NE
Placenta previa (yes vs. no) 1·07 0.32-3·54 0.74 0.17-3·13 NE NE 1·67 0.20-13·8
Preeclampsia/eclampsia (yes vs. no) 1·00 0.68-1·47 1·01 0.63-1·63 0.33 0.04-2·42 1·44 0.50-4·19
Postpartum hemorrhage (yes vs. no) 1·15 0.86-1·54 1·27 0.93-1·74 1·63 0.78-3·37 1·78 0.88-3·59
Neonatal conditions diagnosed in the first year after birth
Congenital hypothyroidism (yes vs. no) 2·86 0.59-13·8 NE NE 20.0 1·81-221 NE NE
Neonatal jaundice (yes vs. no) 1·36 0.85-2·18 1·05 0.25-4·52 0.37 0.05-2·79 NE NE
a

From conditional logistic regression models, conditioned on birth year (of the case), sex, country, and county of birth

b

In unconditional logistic regression models (adjusting for the matching factors), the OR is 216 (95% CI 87-541), based on 19 exposed cases (59%) and 3 exposed controls (1%)